Cadila Rejects Aciloc Ban Reports has become the latest talking point after the company issued a detailed clarification.
The global obesity treatment landscape is entering a transformative phase, As the new oral therapy begins to redefine patient's access to and adherence to weight loss medications
The India-UK FTA has sparked a fresh debate across India's pharmaceutical sector. Drugmakers see the agreement as a major export opportunity.
India strengthening of healthcare quality and innovation has received a major boost with a new collaboration between the central and state governments
The new regulatory move on brand name extension marks a significant step strengthening drug safety and reducing patient confusion in Indian pharma
Covid precautions have returned to focus after Andhra Pradesh reported two Covid deaths and eight active Covid cases.
India Creates Global First as CDSCO Clears Synthetic CBD Therapy with the approval of a prescription treatment for anxiety disorders.
Biogen’s continued focus on developing an effective alzhiemers drug reflects progress and uncertainty in the global fight against the disease
Generic Semaglutide has helped Sun Pharmaceutical Industries expand its global presence with a fresh regulatory win.
India is positioning medical research as a central pillar in its long-term strategy to achieve developed nation status by 2047
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")